2010, Volume 3, Issue 4, pp 454 – 457

Methylenetetrahydrofolate dehydrogenase (MTHFD) enzyme polymorphism as a maternal risk factor for trisomy 21: a clinical study

SCImago Journal & Country Rank

Issues

Special Issues

Authors and Affiliations

Correspondence to:Daniela Neagos, ‘Carol Davila’ University of Medicine and Pharmacy, Department of Genetics, Bucharest, Romania, 19–21 Dimitrie Gerota Street, District 2, Romania, e-mail delia_neagos05@yahoo.com

Abstract

Recent reports linking Down syndrome (DS) to maternal polymorphism at the methylenetetrahydrofolate dehydrogenase (MTHFD) locus have generated a great interest among investigators in the field. In the current study, we examine one genetic polymorphism involved in homocysteine/folate pathway as a risk factor for DS in a Romanian urban–area women cohort. Our results show that the frequencies of MTHFD1 alleles, as well as the frequencies of MTHFD11958 genotypes (GG, GA, AA, GA+AA) do not correlate with DS pregnancies, demonstrating no difference between the case and control groups, as opposed to the findings of Scala et al. (2006) on an Italian cohort.

Keywords

About this article

PMC ID: 3019079
PubMed ID: 21254748
DOI: 

Article Publishing Date (print): 15-11-2010
Available Online: 25-11-2010

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.


SCImago Journal & Country Rank

Issues

Special Issues